SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
inversions
inversions
Finance
Failed Pfizer-Allergan Merger Had Hedge Funds Scrambling in Q2
By
Reuters
and
Aaron Task
August 15, 2016
Finance
Big Business Groups Just Sued the Government for Blocking the Pfizer-Allergan Merger
By
Jen Wieczner
August 4, 2016
Finance
Corporate Deserters Are Still Getting Help From the Government
By
Chris Matthews
June 14, 2016
Finance
Why the Pfizer-Allergan Deal Was a Bad Idea From the Start
By
Alan Murray
April 6, 2016
Finance
Pfizer, Allergan to Mutually Terminate Merger
By
Reuters
April 6, 2016
Finance
Pfizer Could Be Abandoning Its Deal With Allergan
By
Reuters
April 5, 2016
Leadership
Here Are the Companies Donald Trump Would Go After as President
By
Ben Geier
March 16, 2016
Leadership
Tyco-Johnson Controls Gives Us a Window into the Business World’s Hardest Challenges
By
Geoff Colvin
January 27, 2016
Leadership
Hillary Clinton Has a New Plan to Crack Down on Corporate Tax Dodgers
By
Reuters
December 10, 2015
Leadership
Why Washington is Tackling the Tax Inversion Problem All Wrong
By
Chris Matthews
November 25, 2015
Finance
Pfizer’s Allergan Deal is an Even Bigger Tax Dodge Than It’s Claiming
By
Stephen Gandel
November 24, 2015
Finance
Why New Tax Inversion Rules Won’t Stop Pfizer-Allergan Deal
By
Stephen Gandel
November 20, 2015
Finance
Pfizer-Allergan could be a super inversion deal
By
Stephen Gandel
October 29, 2015
Finance
Carl Icahn pledges $150 million to fight tax inversions
By
Michal Addady
October 21, 2015
15 fabulous Fortune reads from 2014
By
Verne Kopytoff
December 27, 2014
Most Popular
Success
Multimillion-dollar restaurant CEO used to splurge on Range Rovers and McLarens—but he’s reining it in now because...
By
Emma Burleigh
Tech
‘Yes, you read that correctly’: Tesla pay committee pitches $1 trillion pact to keep Elon Musk as CEO for long term
By
Nick Lichtenberg
Success
Millionaire Alexis Ohanian walked out of the LSAT 20 minutes in, went to a Waffle House, and decided he was ‘gonna...
By
Preston Fore